✦ LIBER ✦

A case of manic episode during treatment with 5-fluorouracil, epirubicin and cyclophosphamide for breast cancer

✍ Scribed by Isabella Pacchiarotti; Lorenzo Mazzarini; Patrizia Pellegrini; Viola Venturelli; Gabriele Sani; José Sánchez-Moreno; Iginia Mancinelli; Roberto Tatarelli; Giorgio D. Kotzalidis; Paolo Girardi

Book ID: 113635475
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 106 KB
Volume: 29
Category: Article
ISSN: 0163-8343
DOI: 10.1016/j.genhosppsych.2007.04.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant Therapy of Breast Cancer with P

Adjuvant Therapy of Breast Cancer with Pirarubicin Versus Epirubicin in Combination with Cyclophosphamide and 5-fluorouracil

✍ Jun-Jie Li; Gen-Hong Di; Li-Chen Tang; Ke-Da Yu; Zhen Hu; Guang-Yu Liu; Jing-Son 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

Treatment of metastatic breast cancer wi

Treatment of metastatic breast cancer with the combination of ifosfamide, epirubicin and 5-fluorouracil

✍ A. Ghavamzadeh 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 260 KB

Phase I trial of adjuvant chemotherapy w

Phase I trial of adjuvant chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil (CEF) for stage II breast cancer

✍ Stephen E. Jones; Robert G. Mennel; George N. Peters; Mary Alice Westrick; Barry 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 263 KB

Epirubicin is a new anthracycline with a potentially more favorable toxicity profile than the parent compound, doxorubicin. Accordingly, the feasibility and toxicity of 6 courses of adjuvant chemotherapy with cyclophosphamide (C), epirubicin (E), and 5-fluorouracil (F) were assessed in 10 patients w

435 PUBLICATION Comparison of epirubicin

435 PUBLICATION Comparison of epirubicin and vinorelbine with cyclophosphamide, epirubicin, and fluorouracil as neoadjuvant chemotherapy for operable breast cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Mortality during adjuvant treatment of e

Mortality during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil

✍ Marco Colleoni; Karen N Price; Monica Castiglione-Gertsch; Richard D Gelber; Ala 📂 Article 📅 1999 🏛 The Lancet 🌐 English ⚖ 37 KB

Risk of venous thromboembolism in patien

Risk of venous thromboembolism in patients receiving adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide for early breast cancer

✍ Julia HOY; Teresa NEEMAN; Robin STUART-HARRIS; Alison DAVIS 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB